JP2017014155A5 - - Google Patents

Download PDF

Info

Publication number: JP2017014155A5
Authority: JP; Japan
Prior art keywords: vitamin; composition according; protective composition; retinal protective; compound
Prior art date: 2015-07-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2015133034A

Other languages

English (en)

Japanese (ja)

Other versions

JP6647809B2 (ja

JP2017014155A (ja

Filing date

2015-07-01

Publication date

2019-03-22

2015-07-01 Priority claimed from JP2015133034A external-priority patent/JP6647809B2/ja

2015-07-01 Priority to JP2015133034A priority Critical patent/JP6647809B2/ja

2015-07-01 Application filed filed Critical

2017-01-19 Publication of JP2017014155A publication Critical patent/JP2017014155A/ja

2019-03-22 Publication of JP2017014155A5 publication Critical patent/JP2017014155A5/ja

2020-01-15 Priority to JP2020004361A priority patent/JP6978103B2/ja

2020-02-14 Publication of JP6647809B2 publication Critical patent/JP6647809B2/ja

2020-02-14 Application granted granted Critical

2021-11-04 Priority to JP2021180408A priority patent/JP7364252B2/ja

2023-09-27 Priority to JP2023164685A priority patent/JP2023165886A/ja

2025-06-06 Priority to JP2025094684A priority patent/JP2025164766A/ja

Status Active legal-status Critical Current

2035-07-01 Anticipated expiration legal-status Critical

Links

230000001681 protective effect Effects 0.000 claims 7
230000002207 retinal effect Effects 0.000 claims 7
239000000203 mixture Substances 0.000 claims 6
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
239000004480 active ingredient Substances 0.000 claims 2
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
244000017020 Ipomoea batatas Species 0.000 claims 1
235000002678 Ipomoea batatas Nutrition 0.000 claims 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
244000046146 Pueraria lobata Species 0.000 claims 1
235000010575 Pueraria lobata Nutrition 0.000 claims 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
229920001800 Shellac Polymers 0.000 claims 1
244000078534 Vaccinium myrtillus Species 0.000 claims 1
235000017537 Vaccinium myrtillus Nutrition 0.000 claims 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
229930003779 Vitamin B12 Natural products 0.000 claims 1
229930003268 Vitamin C Natural products 0.000 claims 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
229930003448 Vitamin K Natural products 0.000 claims 1
239000002253 acid Substances 0.000 claims 1
235000013793 astaxanthin Nutrition 0.000 claims 1
MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims 1
229940022405 astaxanthin Drugs 0.000 claims 1
239000001168 astaxanthin Substances 0.000 claims 1
229940043430 calcium compound Drugs 0.000 claims 1
150000001674 calcium compounds Chemical class 0.000 claims 1
239000002775 capsule Substances 0.000 claims 1
239000003795 chemical substances by application Substances 0.000 claims 1
150000001845 chromium compounds Chemical class 0.000 claims 1
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
235000013922 glutamic acid Nutrition 0.000 claims 1
239000004220 glutamic acid Substances 0.000 claims 1
239000008187 granular material Substances 0.000 claims 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
235000014304 histidine Nutrition 0.000 claims 1
150000002506 iron compounds Chemical class 0.000 claims 1
239000007788 liquid Substances 0.000 claims 1
229930182817 methionine Natural products 0.000 claims 1
235000006109 methionine Nutrition 0.000 claims 1
238000000034 method Methods 0.000 claims 1
239000005078 molybdenum compound Substances 0.000 claims 1
150000002752 molybdenum compounds Chemical class 0.000 claims 1
SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims 1
239000000843 powder Substances 0.000 claims 1
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 1
235000004400 serine Nutrition 0.000 claims 1
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims 1
229940113147 shellac Drugs 0.000 claims 1
235000013874 shellac Nutrition 0.000 claims 1
239000004208 shellac Substances 0.000 claims 1
239000003826 tablet Substances 0.000 claims 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
235000002374 tyrosine Nutrition 0.000 claims 1
239000004474 valine Substances 0.000 claims 1
235000014393 valine Nutrition 0.000 claims 1
235000019163 vitamin B12 Nutrition 0.000 claims 1
239000011715 vitamin B12 Substances 0.000 claims 1
235000019158 vitamin B6 Nutrition 0.000 claims 1
239000011726 vitamin B6 Substances 0.000 claims 1
235000019154 vitamin C Nutrition 0.000 claims 1
239000011718 vitamin C Substances 0.000 claims 1
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims 1
235000005282 vitamin D3 Nutrition 0.000 claims 1
239000011647 vitamin D3 Substances 0.000 claims 1
235000019168 vitamin K Nutrition 0.000 claims 1
239000011712 vitamin K Substances 0.000 claims 1
150000003721 vitamin K derivatives Chemical class 0.000 claims 1
229940011671 vitamin b6 Drugs 0.000 claims 1
229940021056 vitamin d3 Drugs 0.000 claims 1
229940046010 vitamin k Drugs 0.000 claims 1
150000003752 zinc compounds Chemical class 0.000 claims 1

JP2015133034A 2015-07-01 2015-07-01 網膜保護組成物 Active JP6647809B2 (ja)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
JP2015133034A JP6647809B2 (ja)	2015-07-01	2015-07-01	網膜保護組成物
JP2020004361A JP6978103B2 (ja)	2015-07-01	2020-01-15	網膜保護組成物
JP2021180408A JP7364252B2 (ja)	2015-07-01	2021-11-04	網膜保護組成物
JP2023164685A JP2023165886A (ja)	2015-07-01	2023-09-27	網膜保護組成物
JP2025094684A JP2025164766A (ja)	2015-07-01	2025-06-06	網膜保護組成物

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2015133034A JP6647809B2 (ja)	2015-07-01	2015-07-01	網膜保護組成物

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2020004361A Division JP6978103B2 (ja)	2015-07-01	2020-01-15	網膜保護組成物

Publications (3)

Publication Number	Publication Date
JP2017014155A JP2017014155A (ja)	2017-01-19
JP2017014155A5 true JP2017014155A5 (fr)	2019-03-22
JP6647809B2 JP6647809B2 (ja)	2020-02-14

Family

ID=57829125

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
JP2015133034A Active JP6647809B2 (ja)	2015-07-01	2015-07-01	網膜保護組成物
JP2020004361A Active JP6978103B2 (ja)	2015-07-01	2020-01-15	網膜保護組成物
JP2021180408A Active JP7364252B2 (ja)	2015-07-01	2021-11-04	網膜保護組成物
JP2023164685A Pending JP2023165886A (ja)	2015-07-01	2023-09-27	網膜保護組成物
JP2025094684A Pending JP2025164766A (ja)	2015-07-01	2025-06-06	網膜保護組成物

Family Applications After (4)

Application Number	Title	Priority Date	Filing Date
JP2020004361A Active JP6978103B2 (ja)	2015-07-01	2020-01-15	網膜保護組成物
JP2021180408A Active JP7364252B2 (ja)	2015-07-01	2021-11-04	網膜保護組成物
JP2023164685A Pending JP2023165886A (ja)	2015-07-01	2023-09-27	網膜保護組成物
JP2025094684A Pending JP2025164766A (ja)	2015-07-01	2025-06-06	網膜保護組成物

Country Status (1)

Country	Link
JP (5)	JP6647809B2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2019019072A (ja) *	2017-07-14	2019-02-07	寿スピリッツ株式会社	網膜保護剤の製造方法および網膜保護剤
WO2019151405A1 (fr) *	2018-02-02	2019-08-08	ニプロ株式会社	Comprimés et leur procédé de production
JP2021158985A (ja) *	2020-03-31	2021-10-11	株式会社東洋新薬	経口組成物
JP7231232B2 (ja) *	2020-03-31	2023-03-01	株式会社東洋新薬	経口組成物
CN112544773A (zh) *	2020-12-09	2021-03-26	光明乳业股份有限公司	一种冰淇淋原料组合物、冰淇淋及其制备方法
TW202600024A (zh) *	2024-03-04	2026-01-01	日商花王股份有限公司	固形食品

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07107920A (ja) *	1993-10-12	1995-04-25	Nichiwa Sangyo Kk	鶏用飼料
US6582721B1 (en) *	1999-09-17	2003-06-24	Alcon, Inc.	Stable carotene-xanthophyll beadlet compositions and methods of use
JP2003238442A (ja) *	2002-02-19	2003-08-27	Sunnyhealth Co Ltd	眼健康指向性組成物
CN1281149C (zh) *	2004-11-04	2006-10-25	中山大学	一种石斑鱼诱食剂及其制备方法
JP2007238441A (ja) *	2004-12-03	2007-09-20	Fuji Chem Ind Co Ltd	アスタキサンチンを有効成分とする体脂肪減少用組成物
JP2006347927A (ja) *	2005-06-14	2006-12-28	Fuji Chem Ind Co Ltd	疲労改善剤
ITPD20050224A1 (it) *	2005-07-19	2007-01-20	Actimex Srl	Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego
EP1938810B1 (fr) *	2005-09-30	2014-06-18	Fuji Chemical Industry Co., Ltd.	Agent d'amelioration pour le syndrome metabolique
JP2007126455A (ja) *	2005-10-07	2007-05-24	Fuji Chem Ind Co Ltd	脳機能障害の改善剤
JP2008239619A (ja) *	2007-02-28	2008-10-09	Fuji Chem Ind Co Ltd	末梢血行改善組成物
CA2738357C (fr) *	2011-04-07	2019-08-06	Premium Vitamins And Supplements, L.L.C. D/B/A Nugevity	Methodes et compositions visant a favoriser la sante ocluaire
JP2012246244A (ja) *	2011-05-26	2012-12-13	Fuji Chem Ind Co Ltd	毛細血管退行抑制剤
US20140170247A1 (en) *	2012-09-14	2014-06-19	Guardion Health Sciences, Llc	Emulsion of Carotenoids and Ocular Antioxidants
CN103860625A (zh) *	2013-02-20	2014-06-18	成都尖卡斌科技有限公司	越橘提取物眼用制剂及其制备方法和用途
CN104431532A (zh) *	2014-12-10	2015-03-25	青岛德润电池材料有限公司	一种加快生长的鲫鱼饲料及其制备方法

2015
- 2015-07-01 JP JP2015133034A patent/JP6647809B2/ja active Active
2020
- 2020-01-15 JP JP2020004361A patent/JP6978103B2/ja active Active
2021
- 2021-11-04 JP JP2021180408A patent/JP7364252B2/ja active Active
2023
- 2023-09-27 JP JP2023164685A patent/JP2023165886A/ja active Pending
2025
- 2025-06-06 JP JP2025094684A patent/JP2025164766A/ja active Pending

Similar Documents

Publication	Publication Date	Title
JP2017014155A5 (fr)	2019-03-22
PH12020550341A1 (en)	2021-02-15	Niraparib formulations
MX2020002271A (es)	2020-10-05	Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
HK1219943A1 (zh)	2017-04-21	用於治疗眼科疾病和障害的取代3-苯基丙胺衍生物
EP3176163A4 (fr)	2018-01-10	Nouveau derive d'indene, son procede de preparation, et composition pharmaceutique pour la prevention ou le traitement de maladies retiniennes en contenant comme principe actif
MY193740A (en)	2022-10-27	"substituted 2,4 diamino-quinoline as new anticancer agents"
WO2016046260A8 (fr)	2017-04-13	Composés de 1-alkyl-6-oxo-1,6-dihydropyridin-3-yle et leur utilisation comme modulateurs sgrm
EP3231436A4 (fr)	2018-07-25	Composition pharmaceutique pour la prévention ou le traitement d'une maladie métabolique, comprenant des bactéries bacteroides acidifaciens utilisées comme principe actif efficace
EA202191683A1 (ru)	2021-09-01	Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии
PT3604304T (pt)	2022-11-30	Composto derivado de pirrolo-piridina, método para a sua preparação e composição farmacêutica que o contém como substância ativa para prevenção ou tratamento de doenças relacionadas com proteína quinase
EP4272832A3 (fr)	2023-11-22	Composés antimicrobiens, compositions et leurs utilisations
WO2015001541A3 (fr)	2015-11-26	Composition de film pharmaceutique
WO2016074641A8 (fr)	2016-10-20	Utilisation de nadh ou de sel de celle-ci dans la préparation de produit médicamenteux ou de soins de santé pour le traitement de la phénylcétonurie
NZ767710A (en)	2023-09-29	Ocular formulations for drug-delivery and protection of the anterior segment of the eye
EP3138834A4 (fr)	2017-11-22	Dérivé de cyclohexène, son procédé de préparation et composition pharmaceutique pour prévenir ou traiter des maladies métaboliques, contenant celui-ci comme principe actif
EP3248603A4 (fr)	2017-12-27	Composition pharmaceutique destinée à la prévention, au traitement ou au ralentissement de la maladie d'alzheimer ou de la démence contenant un agent de type récepteur couplé à une protéine g 19 comme principe actif
WO2016006974A3 (fr)	2016-07-21	Nouveaux dérivés triazolopyrimidinone ou triazolopyridinone et leur utilisation
JP2017008001A5 (fr)	2019-03-14
EP3352750A4 (fr)	2018-08-01	Dérivé de cyclohexène, son procédé de préparation et composition pharmaceutique pour prévenir ou traiter une maladie métabolique, contenant ledit dérivé comme principe actif
EP3698801A4 (fr)	2021-07-21	Composition pharmaceutique pour prévenir et traiter le diabète contenant un sel de zinc, un cyclo-hispro et un antidiabétique à titre de principes actifs
WO2016006975A3 (fr)	2016-07-21	Nouveaux dérivés imidazotriazinone ou imidazopyrazinone et leur utilisation
EP3795170A4 (fr)	2022-04-13	Composition pharmaceutique comprenant du ccn5 utilisé comme ingrédient efficace pour la prévention ou le traitement d'une maladie rétinienne
JP2016210757A5 (fr)	2019-03-14
PH12016501205A1 (en)	2016-08-15	Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
WO2015104666A3 (fr)	2015-11-12	Composition pharmaceutique de fingolimod